This grant, the Neurofibromatosis Research Program Clinical Trial Award, is for supporting innovative research designed to significantly advance the treatment and management of Neurofibromatosis (NF). It aims to fund clinical trials that evaluate promising new medical products, including pharmacologic agents (drugs or biologics), medical devices, and novel clinical guidance or emerging technologies. Projects can span the entire spectrum of clinical research, from small-scale proof-of-concept studies like pilot or first-in-human trials, intended to establish feasibility or inform larger designs, all the way to comprehensive, large-scale trials focused on determining the efficacy of interventions within relevant patient populations. The goal is to bring impactful new therapies to those affected by NF.
Opportunity ID: 294422
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-17-NFRP-CTA |
| Funding Opportunity Title: | DoD Neurofibromatosis Research Program, Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 06, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Aug 09, 2017 |
| Current Closing Date for Applications: | Aug 09, 2017 |
| Archive Date: | Sep 08, 2017 |
| Estimated Total Program Funding: | $1,440,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The NFRP Clinical Trial Award supports research with the potential to have a major impact on the treatment or management of NF. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept (i.e., pilot, first-in-human, or Phase 0) trials to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:Email: help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 294422 Full Announcement-FY17 NFRP CTA -> NFRP_FY17 CTA PA_GG.PDF
Folder 294422 Full Announcement-FY17 NFRP CTA -> NFRP_FY17_CTA_IND_Documenation_Form_GG.PDF
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00233014 | Jun 06, 2017 | Aug 09, 2017 | View |
Package 1
Mandatory forms
294422 RR_SF424_2_0-2.0.pdf
294422 RR_Budget_1_4-1.4.pdf
294422 RR_KeyPersonExpanded_2_0-2.0.pdf
294422 PerformanceSite_2_0-2.0.pdf
294422 AttachmentForm_1_2-1.2.pdf
Optional forms
294422 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
